Neith Corporation (TPEX:6236)
15.25
+0.35 (2.35%)
Nov 20, 2026, 9:08 AM CST
Neith Market Cap
Neith has a market cap or net worth of 635.22 million as of November 20, 2026. It is the 36,707th most valuable company in the world and the 2,170th biggest in Taiwan. Its market cap has decreased by 47.95% in one year.
Market Cap
635.22M
Enterprise Value
498.96M
Revenue
32.29M
Global Rank
Country Rank
#2,170 Taiwan
PE Ratio
1,096.10
ChartMarket Cap Chart
Since November 3, 2004, Neith's market cap has increased from 483.77M to 635.22M, an increase of 31.31%. That is a compound annual growth rate of 1.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 635.22M | -29.23% |
| Dec 30, 2025 | 897.64M | -27.93% |
| Dec 27, 2024 | 1.25B | -13.21% |
| Dec 29, 2023 | 1.43B | 166.67% |
| Dec 30, 2022 | 538.12M | 47.83% |
| Dec 30, 2021 | 364.02M | 7.98% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BiOptic | 866.92M |
| TCI GENE | 859.90M |
| Lukas Biomedical | 789.33M |
| Holy Stone Healthcare | 759.06M |
| BioLASCO Taiwan | 718.42M |
| GeneReach Biotechnology | 693.67M |
| Meribank Biotech | 671.83M |
| NatureWise Biotech & Medicals | 656.59M |